Microzide and Profen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Microzide (hydrochlorothiazide) and Profen (ibuprofen). Common drug interactions include immediate post-injection reaction among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Microzide and Profen. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Microzide?

Microzide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 994 Microzide users. Check the latest studies of Microzide.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.



On Aug, 06, 2026

34 people who take Microzide and Profen together, and have interactions are studied.

Microzide and Profen drug interactions.

What are the common drug interactions of Microzide and Profen, by gender? *:

female:

  1. Immediate post-injection reaction
  2. Injection site erythema (redness at injection site)
  3. Injection site pruritus (severe itching at injection site)
  4. Injection site swelling
  5. Injection site warmth
  6. Lip swelling
  7. Malignant neoplasm progression (cancer tumour came back)
  8. Mastoiditis (infection of mastoid bone)
  9. Meningioma (a diverse set of tumours arising from the meninges)
  10. Oedema peripheral (superficial swelling)

male:

  1. Anxiety
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Abdominal pain
  4. Anaemia (lack of blood)
  5. Arthralgia (joint pain)
  6. Back injury
  7. Blindness
  8. Blood sodium decreased
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Chest pain

What are the common drug interactions of Microzide and Profen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Overdose
  2. Respiratory depression (respiration has a rate below 12 breaths)
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Weight increased

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Palpitations (feelings or sensations that your heart is pounding or racing)
  5. Proteinuria (presence of protein in the urine)
  6. Renal disorder (kidney disease)
  7. Renal impairment (severely reduced kidney function)
  8. Ventricular extrasystoles (premature cardiac contraction)
  9. Oropharyngeal pain

50-59:

  1. Back injury
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Chronic kidney disease
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Fall
  6. Feeling hot
  7. Haematoma (collection of blood outside the blood vessels)
  8. Lumbar vertebral fracture
  9. Pericardial effusion malignant (cancerous fluid around the heart)
  10. Renal failure (kidney dysfunction)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Metastases to lymph nodes (cancer spreads to lymph node)
  4. Metastases to pancreas (cancer spreads to pancreas)
  5. Metastases to spleen (cancer spreads to spleen)
  6. Metastatic malignant melanoma (spreadable cancer tumour of melanine)
  7. Nausea (feeling of having an urge to vomit)
  8. Pericardial effusion (fluid around the heart)
  9. Swelling face
  10. Anaemia (lack of blood)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 8 people, 23.53%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 17.65%
  3. Muscle Spasms (muscle contraction): 5 people, 14.71%
  4. Stress And Anxiety: 4 people, 11.76%
  5. Infection: 4 people, 11.76%
  6. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 3 people, 8.82%
  7. Fever: 3 people, 8.82%
  8. High Blood Cholesterol: 3 people, 8.82%
  9. Hypersensitivity: 3 people, 8.82%
  10. Itching: 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take Microzide and Profen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Microzide and Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Microzide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Profen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Microzide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Profen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide and ibuprofen (the active ingredients of Microzide and Profen, respectively), and Microzide and Profen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: